Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis).
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22661840
Conclusion of this study
Patients of first group were administered with 500 mg capsule of Shallaki, 6 g per day (in three divided doses) with lukewarm water (n=29) and the second group) capsule Shallaki as above along with local application of Shallaki ointment on the affected joints (n=23). After a course of therapy for 2 months, symptomatic improvement was observed in both the groups at various levels with promising results in the patients of first group.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study